NCT04772794

Brief Summary

During anesthesia and surgery, oxygen is routinely administered to all patients. Inspired oxygen concentrations, however, vary between 30% - 100% and oxygen is often administered in a seemingly random manner.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 13, 2020

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 23, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 26, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

February 26, 2021

Status Verified

February 1, 2021

Enrollment Period

2 years

First QC Date

February 23, 2021

Last Update Submit

February 23, 2021

Conditions

Keywords

fraction of inspired oxygenhyperoxiaimmune system

Outcome Measures

Primary Outcomes (2)

  • changes in serum level of interlukin 6

    serum level of interlukin 6 will be measured by ELISA technique

    before operation (0), 1st, 3rd, and 7th days postoperative

  • changes in serum level of interlukin 10

    serum level of interlukin 6 will be measured by ELISA technique

    before operation (0), 1st, 3rd, and 7th days postoperative

Secondary Outcomes (1)

  • changes in total WBCs count

    before operation (0), 1st, 3rd, and 7th days postoperative

Study Arms (2)

hyperoxygenation group

ACTIVE COMPARATOR

Intraoperative administration of a mixture of 80% oxygen and 20% air

Other: fraction of inspired oxygen

control group

PLACEBO COMPARATOR

intraoperative administration of 30% oxygen and 70% air

Other: fraction of inspired oxygen

Interventions

after induction of general anaesthesia, different fraction of inspired oxygen will be given to patient according to their group allocation

control grouphyperoxygenation group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • candidates for abdominal cancer surgeries

You may not qualify if:

  • Patients with chronic diseases, such as chronic obstructive pulmonary disease or pneumonia,
  • body mass index (BMI) \>35 kg/m2,
  • severe malnutrition (albumin \<3),
  • leukopenia (white blood cell \<4,000 g/dL),
  • surgery within the previous 30 days and
  • O2 saturation \< 90%, as measured using a pulse oximeter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University

Asyut, 171516, Egypt

RECRUITING

MeSH Terms

Conditions

Hyperoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Shereen M Kamal, Associate Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 23, 2021

First Posted

February 26, 2021

Study Start

January 13, 2020

Primary Completion

January 1, 2022

Study Completion

May 1, 2022

Last Updated

February 26, 2021

Record last verified: 2021-02

Locations